Low-Level Endothelial TRAIL-Receptor Expression Obstructs the CNS-Delivery of Angiopep-2 Functionalised TRAIL-Receptor Agonists for the Treatment of Glioblastoma

Low-Level Endothelial TRAIL-Receptor Expression Obstructs the CNS-Delivery of Angiopep-2 Functionalised TRAIL-Receptor Agonists for the Treatment of Glioblastoma

Glioblastoma (GBM) is the most malignant and aggressive form of glioma and is associated with a poor survival rate. Latest generation Tumour Necrosis Factor Related Apoptosis-Inducing Ligand (TRAIL)-based therapeutics potently induce apoptosis in cancer cells, including GBM cells, by binding to deat...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Nivetha Krishna Moorthy, Oliver Seifert, Stephan Eisler, Sara Weirich, Roland E. Kontermann, Markus Rehm, Gavin Fullstone
Format: Artikel
Sprache:English
Veröffentlicht: MDPI AG 2021-12-01
Schriftenreihe:Molecules
Schlagworte:
glioblastoma
TRAIL
angiopep-2
CNS delivery
receptor-mediated transcytosis
blood–brain barrier
Online Zugang:https://www.mdpi.com/1420-3049/26/24/7582

Ähnliche Einträge

Ähnliche Einträge